We envision a world where newborns are scientifically insulated from trial-and-error nutrition—ensuring that every fragile life receives the precise, dedicated care they deserve.
Every drop of human milk is dynamically unique, yet modern clinical fortification remains a silent guessing game.
Vital nutritional parameters remain completely invisible at the point of care, creating a profound clinical blindspot and placing an intense operational burden on neonatal units.
Not a deficit of devotion—a boundary of legacy technology.
Meticulously designed for medical institutions where exceptional outcomes are the single standard.
We replace clinical estimation with absolute measurement, embedding molecular precision directly into high-acuity workflows.
We have consistently engineered our systems to replace institutional estimation with absolute measurement, embedding data transparency directly into high-acuity clinical workflows.
A point-of-care sensor designed to profile critical nutritional targets from a few drops. By routing signals electronically rather than fluidically, it completely avoids internal clogging to deliver rapid bedside precision.
A mathematically auditable neural layer that instantly translates complex biochemical data into guideline-compliant insights, integrating seamlessly into core hospital networks to remove cognitive burden.
Localized robotic execution that prepares precise formulations safely at the point of care. By eliminating manual hand-mixing, it beautifully protects high-acuity care pathways where the stakes are highest.
The true clinical breakthrough is not merely a more precise sensor. It is the absolute elimination of clinical guesswork. A precise measurement that fails to execute does not transform care—the loop must close, or it cannot help.
From conceptualization to integrated clinical readiness.
Verified correlation against gold-standard laboratory assays.
Cross-border pipeline anchoring: HKSTP · Hetao Shenzhen-HK Zone.
Hong Kong · China · Thailand · Austria. Workflow co-design and pilot sites.
Adaptable software over rigid hardware, our ecosystem scales seamlessly to automate quality control without disrupting clinical workflows.
Co-designed alongside the world's most rigorous academic and research institutions, the infrastructure is architected natively to integrate with diverse institutional protocols—establishing an automated, fully traceable standard of care that optimizes patient throughput, minimizes institutional risk, and sets localized quality benchmarks.
The NICU is our definitive proof point.
The broader clinical enterprise is our ultimate destination.
Deep-tech infrastructure shaped by specialists from Japan's elite research institutions and proven within high-scale commercial enterprises.
Holding a Ph.D. in Biomolecular Engineering from Nagoya University, Piyawan serves as an In-house Entrepreneur within the HKSAR Government’s InnoHK initiative at ABIC, where Neotrient was designated a Flagship Translational Project.
Previously, she was a Product Researcher for a venture-backed Bio-AI diagnostics innovator in Japan, leading R&D expansions through a $100 Million valuation milestone. This cross-functional exposure across product lifecycles, team scaling, and commercial campaigns forged her unique capability as an executive operator who bridges advanced science with market execution.
Chaiyanut directs Neotrient’s closed-loop architecture, unifying advanced artificial intelligence with precision robotics. Previously, he served as Lead Data Scientist for a premier industrial AI platform, engineering machine learning frameworks utilized by Fortune Global 500 conglomerates.
A specialist in pattern recognition and signal processing with over 10 peer-reviewed scientific publications, his expertise spans both algorithmic intelligence and physical automation. This rare cross-disciplinary mastery allows him to seamlessly translate complex data into the automated, high-precision clinical workflows required at the point of care.
Our team achieved full integration readiness in 5 months.
We left established corporate and research trajectories in Japan to build Neotrient.
Our translation from laboratory to clinical environment is anchored by elite institutional frameworks—combining deep-tech infrastructure with tier-one government and academic backing.
Incubated within a world-class translational research environment.
Backed by the HKSAR Government’s flagship innovation cluster.
Headquartered at Hong Kong’s premier innovation park.